Evangelos Digkas
- E-post:
- evangelos.digkas@igp.uu.se
- Besöksadress:
- Akademiska sjukhuset, ingång 100/101
751 85 Uppsala - Postadress:
- Akademiska sjukhuset, ingång 100/101
751 85 Uppsala
Läkare vid Institutionen för immunologi, genetik och patologi; Kliniska verksamheter; Klinisk genetik
- E-post:
- evangelos.digkas@igp.uu.se
- Besöksadress:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postadress:
- Rudbecklaboratoriet
751 85 Uppsala
Publikationer
Senaste publikationer
-
Ingår i Journal of Geriatric Oncology, 2026
- DOI för CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study
- Ladda ner fulltext (pdf) av CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study
-
Ingår i BMC Health Services Research, 2026
- DOI för A mixed-methods exploration of stakeholder experiences and perspectives on integrating polygenic breast cancer risk scores into Swedish clinical practice
- Ladda ner fulltext (pdf) av A mixed-methods exploration of stakeholder experiences and perspectives on integrating polygenic breast cancer risk scores into Swedish clinical practice
-
Ingår i BMC Cancer, 2026
- DOI för Endocrine therapy and COVID-19 outcomes in women with breast cancer: a nationwide register-based matched cohort study
- Ladda ner fulltext (pdf) av Endocrine therapy and COVID-19 outcomes in women with breast cancer: a nationwide register-based matched cohort study
-
Ingår i Cancer Immunology and Immunotherapy, 2025
- DOI för Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer
- Ladda ner fulltext (pdf) av Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer
-
Ingår i The Breast, 2025
- DOI för Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world setting
- Ladda ner fulltext (pdf) av Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world setting
Alla publikationer
Artiklar i tidskrift
-
Ingår i Journal of Geriatric Oncology, 2026
- DOI för CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study
- Ladda ner fulltext (pdf) av CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study
-
Ingår i BMC Health Services Research, 2026
- DOI för A mixed-methods exploration of stakeholder experiences and perspectives on integrating polygenic breast cancer risk scores into Swedish clinical practice
- Ladda ner fulltext (pdf) av A mixed-methods exploration of stakeholder experiences and perspectives on integrating polygenic breast cancer risk scores into Swedish clinical practice
-
Ingår i BMC Cancer, 2026
- DOI för Endocrine therapy and COVID-19 outcomes in women with breast cancer: a nationwide register-based matched cohort study
- Ladda ner fulltext (pdf) av Endocrine therapy and COVID-19 outcomes in women with breast cancer: a nationwide register-based matched cohort study
-
Ingår i Cancer Immunology and Immunotherapy, 2025
- DOI för Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer
- Ladda ner fulltext (pdf) av Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer
-
Ingår i The Breast, 2025
- DOI för Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world setting
- Ladda ner fulltext (pdf) av Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world setting
-
Ingår i Frontiers in Oncology, 2024
- DOI för Multiple immune-related adverse events secondary to checkpoint inhibitor therapy in patients with advanced cancer: association with treatment effectiveness
- Ladda ner fulltext (pdf) av Multiple immune-related adverse events secondary to checkpoint inhibitor therapy in patients with advanced cancer: association with treatment effectiveness
-
Ingår i Breast Cancer Research and Treatment, s. 79-87, 2024
- DOI för Incidence and risk factors of hypothyroidism after treatment for early breast cancer: a population-based cohort study
- Ladda ner fulltext (pdf) av Incidence and risk factors of hypothyroidism after treatment for early breast cancer: a population-based cohort study
-
Ingår i Pigment Cell & Melanoma Research, 2024
- DOI för The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta-analysis
- Ladda ner fulltext (pdf) av The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta-analysis
-
Ingår i Cancer Medicine, s. 13217-13224, 2023
- DOI för Predicting immune-related adverse events using a simplified frailty score in cancer patients treated with checkpoint inhibitors: A retrospective cohort study
- Ladda ner fulltext (pdf) av Predicting immune-related adverse events using a simplified frailty score in cancer patients treated with checkpoint inhibitors: A retrospective cohort study
Artiklar, forskningsöversikt
-
Ingår i Targeted oncology, s. 507-515, 2022
- DOI för Randomized Versus Real-World Evidence on the Efficacy and Toxicity of Checkpoint Inhibitors in Cancer in Patients with Advanced Non-small Cell Lung Cancer or Melanoma: A Meta-analysis
- Ladda ner fulltext (pdf) av Randomized Versus Real-World Evidence on the Efficacy and Toxicity of Checkpoint Inhibitors in Cancer in Patients with Advanced Non-small Cell Lung Cancer or Melanoma: A Meta-analysis